MarketCapTrends
CRMD
CorMedix Inc. (CRMD)
NASDAQ · Healthcare

CorMedix Inc. Shareholder Equity 2012–2025

CorMedix Inc. annual/quarterly shareholder equity history from 2012 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • CorMedix Inc. shareholder equity for the quarter ending December 31, 2025 were 405.3M, a 378.76% increase year-over-year.
  • CorMedix Inc. shareholder equity for 2025 were 405.3M, a 378.76% increase from 2024.
  • CorMedix Inc. shareholder equity for 2024 were 84.7M, a 53.75% increase from 2022.
  • CorMedix Inc. shareholder equity for 2022 were 55.1M, a 12.32% decrease from 2021.
  • CorMedix Inc. shareholder equity for 2021 were 62.8M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
CorMedix Inc. Annual Shareholder Equity (Millions of US $)
2025$405
2024$85
2022$55
2021$63
2020$44
2019$24
2018$5
2017$7
2016$18
2015$34
2014$4
2013$-4
2012$-0
CorMedix Inc. Quarterly Shareholder Equity (Millions of US $)
2025-12-31$405
2024-12-31$85
2022-12-31$55
2021-12-31$63
2020-12-31$44
2019-12-31$24
2018-12-31$5
2017-12-31$7
2016-12-31$18
2015-12-31$34
2014-12-31$4
2013-12-31$-4
2012-12-31$-0

CorMedix Inc. Shareholder Equity — FAQ

CorMedix Inc. (CRMD) shareholder equity over the last 13 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see CRMD's shareholder equity history?

The chart and table above show CorMedix Inc.'s shareholder equity by year and by quarter, including the growth rate.